Identification of vulnerabilities for pharmacological inhibition of PIP4K2s in Acute Myeloid Leukemia (2023)
- Authors:
- USP affiliated authors: REGO, EDUARDO MAGALHÃES - FM ; MACHADO NETO, JOÃO AGOSTINHO - ICB ; LIMA, KELI CRISTINA DE - FM ; CARVALHO, MARIA FERNANDA LOPES - ICB ; MARTINS, DIEGO ANTONIO PEREIRA - FMRP ; NASCIMENTO, MARIANE CRISTINA DO - FM ; NOGUEIRA, FREDERICO LISBOA - FM
- Unidades: FM; ICB; FMRP
- DOI: 10.1182/blood-2023-189998
- Subjects: FARMACOLOGIA; HEMATOLOGIA; LEUCEMIA MIELOIDE AGUDA; QUIMIOTERAPIA COMBINADA; CÉLULAS CULTIVADAS DE TUMOR; PROLIFERAÇÃO CELULAR; NEOPLASIAS POR TIPO HISTOLÓGICO; ANTINEOPLÁSICOS; PROTEÍNAS; CÉLULAS MIELOIDES
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Publisher: American Society of Hematology
- Publisher place: Washington, DC
- Date published: 2023
- Source:
- Conference titles: 65th ASH Annual Meeting Abstracts
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: bronze
-
ABNT
LIMA, Keli Cristina de et al. Identification of vulnerabilities for pharmacological inhibition of PIP4K2s in Acute Myeloid Leukemia. Blood, v. 142, n. Supl. 1, p. 5774, 2023Tradução . . Disponível em: https://doi.org/10.1182/blood-2023-189998. Acesso em: 03 nov. 2024. -
APA
Lima, K. C. de, Carvalho, M. F. L., Martins, D. A. P., Nascimento, M. C. do, Nogueira, F. L., Medeiros, R. de C. C., et al. (2023). Identification of vulnerabilities for pharmacological inhibition of PIP4K2s in Acute Myeloid Leukemia. Blood, 142( Supl. 1), 5774. doi:10.1182/blood-2023-189998 -
NLM
Lima KC de, Carvalho MFL, Martins DAP, Nascimento MC do, Nogueira FL, Medeiros R de CC, Schuringa JJ, Rego EM, Machado Neto JA. Identification of vulnerabilities for pharmacological inhibition of PIP4K2s in Acute Myeloid Leukemia [Internet]. Blood. 2023 ; 142( Supl. 1): 5774.[citado 2024 nov. 03 ] Available from: https://doi.org/10.1182/blood-2023-189998 -
Vancouver
Lima KC de, Carvalho MFL, Martins DAP, Nascimento MC do, Nogueira FL, Medeiros R de CC, Schuringa JJ, Rego EM, Machado Neto JA. Identification of vulnerabilities for pharmacological inhibition of PIP4K2s in Acute Myeloid Leukemia [Internet]. Blood. 2023 ; 142( Supl. 1): 5774.[citado 2024 nov. 03 ] Available from: https://doi.org/10.1182/blood-2023-189998 - Pharmacological inhibition of PIP4K2 potentiates venetoclax-induced apoptosis in Acute Myeloid Leukemia
- Potency and efficacy of pharmacological PIP4K2 inhibitors in acute lymphoblastic leukemia
- Data mining in acute myeloid leukemia: identification of disease biomarkers, prognostic factors, novel targets, and potential drugs
- Cephalochromin-induced mitochondrial damage overcomes venetoclax-resistance in acute Myeloid Leukemia Models
- Comprehensive analysis of the HCK gene in myeloid neoplasms: insights into biological functions, prognosis, and response to antineoplastic agents
- Potency and efficacy of pharmacological PIP4K2 inhibitors in acute lymphoblastic leukemia
- Transcriptomics analysis identified ezrin as a potential druggable target in cervical and gastric cancer cells
- The PIP4K2 inhibitor THZ-P1-2 exhibits antileukemia activity by disruption of mitochondrial homeostasis and autophagy
- The multikinase inhibitor AD80 induces mitotic catastrophe and autophagy in pancreatic cancer cells
- Exploring redox vulnerabilities in JAK2V617F-positive cellular models
Informações sobre o DOI: 10.1182/blood-2023-189998 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
